Cargando…
Microvascular Angiopathic Consequences of COVID-19
The coronavirus disease-2019 (COVID-19) pandemic has rapidly spread across the world. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan, China in December, 2019. Ever increasing data is continuing to emerge about the impact of COVID-...
Autores principales: | Nalugo, Margaret, Schulte, Linda J., Masood, Muhammad F., Zayed, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884319/ https://www.ncbi.nlm.nih.gov/pubmed/33604359 http://dx.doi.org/10.3389/fcvm.2021.636843 |
Ejemplares similares
-
Vascular Manifestations of COVID-19 – Thromboembolism and Microvascular Dysfunction
por: Roberts, Kirsty A., et al.
Publicado: (2020) -
Microvascular significance of TGF-β axis activation in COVID-19
por: Arguinchona, Lauren M., et al.
Publicado: (2023) -
Blood-pool MRI assessment of myocardial microvascular reactivity
por: Loai, Sadi, et al.
Publicado: (2023) -
Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway
por: Dritsoula, Athina, et al.
Publicado: (2022) -
Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy
por: Loai, Sadi, et al.
Publicado: (2021)